IL137491A0 - Combination preparation of oestrogen and antioestrogen - Google Patents
Combination preparation of oestrogen and antioestrogenInfo
- Publication number
- IL137491A0 IL137491A0 IL13749199A IL13749199A IL137491A0 IL 137491 A0 IL137491 A0 IL 137491A0 IL 13749199 A IL13749199 A IL 13749199A IL 13749199 A IL13749199 A IL 13749199A IL 137491 A0 IL137491 A0 IL 137491A0
- Authority
- IL
- Israel
- Prior art keywords
- antioestrogen
- oestrogen
- combination preparation
- preparation
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19807791A DE19807791A1 (de) | 1998-02-19 | 1998-02-19 | Kombinationspräparat aus Östrogen und Antiöstrogen |
| PCT/EP1999/001023 WO1999042109A1 (de) | 1998-02-19 | 1999-02-18 | Kombinationspräparat aus östrogen und antiöstrogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL137491A0 true IL137491A0 (en) | 2001-07-24 |
Family
ID=7858786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13749199A IL137491A0 (en) | 1998-02-19 | 1999-02-18 | Combination preparation of oestrogen and antioestrogen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6677324B1 (de) |
| EP (1) | EP1054676A1 (de) |
| JP (1) | JP2002503695A (de) |
| AR (1) | AR017982A1 (de) |
| AU (1) | AU2834799A (de) |
| BR (1) | BR9908094A (de) |
| CA (1) | CA2321427A1 (de) |
| DE (1) | DE19807791A1 (de) |
| IL (1) | IL137491A0 (de) |
| PE (1) | PE20000261A1 (de) |
| WO (1) | WO1999042109A1 (de) |
| ZA (1) | ZA991370B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7335650B2 (en) | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
| US6653298B2 (en) | 2000-01-14 | 2003-11-25 | Sterix Limited | Composition |
| DE10039199A1 (de) * | 2000-08-10 | 2002-02-21 | Schering Ag | Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen |
| DE10159217A1 (de) * | 2001-11-27 | 2003-06-05 | Schering Ag | 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate |
| US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| EP1749017A2 (de) * | 2004-05-27 | 2007-02-07 | MIGENIX Corp. | Verbindungen und verfahren für zytoprotektion |
| DE602005023877D1 (de) | 2004-07-27 | 2010-11-11 | Sicor Inc | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide |
| CN101014610B (zh) * | 2004-09-08 | 2012-08-22 | Msd欧斯股份有限公司 | 具有选择性雌激素活性的15β-取代的类固醇 |
| BRPI0618755A2 (pt) | 2005-11-22 | 2011-09-13 | Sumitomo Chemical Co | compostos de enxofre orgánicos e uso destes |
| JP5298631B2 (ja) | 2007-05-18 | 2013-09-25 | 住友化学株式会社 | 有機硫黄化合物及びその有害節足動物防除用途 |
| TW200904329A (en) | 2007-05-18 | 2009-02-01 | Sumitomo Chemical Co | Organic sulfur compound and its use for controlling harmful arthropod |
| JP2009001551A (ja) | 2007-05-18 | 2009-01-08 | Sumitomo Chemical Co Ltd | 有機硫黄化合物及びその有害節足動物防除用途 |
| US8153846B2 (en) * | 2007-12-03 | 2012-04-10 | E.I. Du Pont De Nemours And Company | Sulfur containing fluoroalkyl amines and isocyanates |
| EP2070941A1 (de) | 2007-12-14 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Stereoselektive Synthese von selektiven negativen Regulatoren von Östrogenrezeptoren |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP3936133A1 (de) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natürliche kombinationshormonersatzformulierungen und therapien |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| CN104387435B (zh) * | 2014-12-10 | 2017-05-10 | 天津孚音生物科技发展有限公司 | 一种化合物及其制备方法与应用 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| EP3435977A4 (de) | 2016-04-01 | 2019-10-16 | Therapeuticsmd, Inc. | Pharmazeutische steroidhormonzusammensetzung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
| GB8813353D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Therapeutic product |
| DE3925507A1 (de) | 1989-07-28 | 1991-01-31 | Schering Ag | 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln |
| DE19622457A1 (de) | 1996-05-24 | 1997-11-27 | Schering Ag | 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
| US5866560A (en) * | 1996-08-20 | 1999-02-02 | Schering Ag | 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents |
| DE19635525A1 (de) * | 1996-08-20 | 1998-02-26 | Schering Ag | 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
-
1998
- 1998-02-19 DE DE19807791A patent/DE19807791A1/de not_active Ceased
-
1999
- 1999-02-17 PE PE1999000143A patent/PE20000261A1/es not_active Application Discontinuation
- 1999-02-18 WO PCT/EP1999/001023 patent/WO1999042109A1/de active Application Filing
- 1999-02-18 JP JP2000532124A patent/JP2002503695A/ja not_active Withdrawn
- 1999-02-18 AU AU28347/99A patent/AU2834799A/en not_active Abandoned
- 1999-02-18 BR BR9908094-0A patent/BR9908094A/pt not_active IP Right Cessation
- 1999-02-18 US US09/622,532 patent/US6677324B1/en not_active Expired - Fee Related
- 1999-02-18 EP EP99908916A patent/EP1054676A1/de not_active Withdrawn
- 1999-02-18 CA CA002321427A patent/CA2321427A1/en not_active Abandoned
- 1999-02-18 IL IL13749199A patent/IL137491A0/xx unknown
- 1999-02-19 ZA ZA9901370A patent/ZA991370B/xx unknown
- 1999-02-23 AR ARP990100693A patent/AR017982A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9908094A (pt) | 2000-10-31 |
| CA2321427A1 (en) | 1999-08-26 |
| PE20000261A1 (es) | 2000-05-22 |
| ZA991370B (en) | 1999-11-24 |
| AU2834799A (en) | 1999-09-06 |
| EP1054676A1 (de) | 2000-11-29 |
| AR017982A1 (es) | 2001-10-24 |
| WO1999042109A1 (de) | 1999-08-26 |
| DE19807791A1 (de) | 1999-08-26 |
| US6677324B1 (en) | 2004-01-13 |
| JP2002503695A (ja) | 2002-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL137491A0 (en) | Combination preparation of oestrogen and antioestrogen | |
| ZA995418B (en) | Preparation of sterol and stanol-esters. | |
| IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
| HU229606B1 (en) | Novel combination of loteprednol and antihistamines | |
| IL137411A0 (en) | Novel local anesthetic compounds and uses | |
| HUP0103636A3 (en) | 2-methyl-thieno-benzodiazepine formulation and its use | |
| EP0983958A4 (de) | Fahrtreppenstufe und fahrtreppe | |
| AU2001255013A1 (en) | Combination of growth hormone secretagogues and antidepressants | |
| GB2318802B (en) | Flexible alloy and components made therefrom | |
| TW353886U (en) | Improvement of umbrela rib and stretcher | |
| GB2342182B (en) | Ophthalmoscope and attachment therefor | |
| PL353487A1 (en) | Novel combination of loteprednol and beta2 | |
| PL328334A1 (en) | Preparation and application thereof | |
| AU2002318852A1 (en) | Combination preparation of oestrogen and antioestrogen | |
| EP1066051A4 (de) | Sciellin und seine verwendungen | |
| TW379716U (en) | Structure of packing straps | |
| GB9821044D0 (en) | Anaesthetic and its use | |
| GB9820641D0 (en) | Stabilisation of peroxidases | |
| GB9717828D0 (en) | Medical balloon and medical balloon assembly | |
| GB2350373B (en) | Flexible alloy and components made therefrom | |
| GB9807073D0 (en) | Sunscreens and compositions containing them | |
| GB9807074D0 (en) | Sunscreens and compositions containing them | |
| TW405377U (en) | Improvement of chair structure | |
| TW364377U (en) | Structure of body stretcher | |
| GB9802016D0 (en) | Bootsac and coolsac |